174
M. Schön, R. Naef / Tetrahedron: Asymmetry 10 (1999) 169–176
1047, 791, 764, 706, 696, 589 cm−1. 1H NMR (CDCl3) δ 0.89, 1.00 (2d, J=6 Hz, 6H), 2.36 (s, 3H), 3.10
(h, J=6 Hz, 1H), 3.57 (d, J=4 Hz, 1H), 5.24 (d, J=4 Hz, 1H), 6.9–7.2 (m, 10H). 13C NMR (CDCl3) δ
15.5, 20.1, 32.3, 49.5, 72.6, 74.4, 126.5, 127.0, 17.4, 127.8, 129.9, 137.5, 141.6.
3.2.3. (1R,2S)-N-(3-Pentyl)-N-methyl-2-amino-1,2-diphenylethanol 6
According to the typical procedure given for 5; 1.18 g (5.53 mmol) (1R,2S)-2-amino-1,2-diphenyl-
ethanol; 651 mg (8.30 mmol) sodium cyanoborohydride; 476 mg (5.53 mmol) 3-pentanone; 22 ml
MeOH; reaction time 3 days at r.t.; column chromatography (hexane:EtOAc, 1:1) of the crude product
afforded the pure secondary amine (1.14 g, 73%) as a colourless oil; 0.75 ml HCOOH, 0.19 ml H2O, 0.56
ml 37% aq. H2CO; reaction time 6 h at 100°C; column chromatography (hexane:EtOAc, 9:1) of crude
product afforded ligand 6 (1.02 g, 85%) as a colourless oil. [α]20 −83.0 (c=1.71, CHCl3). Anal. calcd for
D
C20H27NO: C, 80.76; H, 9.15; N, 4.71. Found: C, 80.64; H, 9.28; N, 4.73. IR (neat) 3200–3700, 2962,
1
2932, 2873, 1495, 1453, 1200, 1089, 1054, 1030, 999, 922, 777, 754, 701 cm−1. H NMR (CDCl3) δ
0.69, 0.99 (2t, J=7 Hz, 6H), 1.2–1.6 (m, 4H), 2.36 (s, 3H), 2.45–2.55 (m, 1H), 3.74 (d, J=4 Hz, 1H), 5.33
(d, J=4 Hz, 1H), 6.9–7.2 (m, 10H). 13C NMR (CDCl3) δ 11.9, 12.0, 21.8, 23.6, 32.5, 61.8, 72.7, 74.3,
126.4, 126.9, 127.4, 127.8, 130.2, 132.3, 137.3, 141.5.
3.2.4. (1R,2S)-N-Cyclohexyl-N-methyl-2-amino-1,2-diphenylethanol 7
According to the typical procedure given for 5; 1.18 g (5.53 mmol) (1R,2S)-2-amino-1,2-diphenyl-
ethanol; 651 mg (8.30 mmol) sodium cyanoborohydride; 815 mg (8.30 mmol) cyclohexanone; 22 ml
MeOH; reaction time 3 days at r.t.; column chromatography (hexane:EtOAc, 1:1) of the crude product
afforded the pure secondary amine (860 mg, 52%) as a colourless oil; 1.4 ml HCOOH, 0.35 ml H2O, 1.0
ml 37% aq. H2CO; reaction time 6 h at 100°C; column chromatography (hexane:EtOAc, 2:1) of crude
product afforded ligand 7 (770 mg, 45%) as colourless crystals: mp 87–88°C. [α]20 −74.3 (c=0.44,
D
CHCl3). Anal. calcd for C21H27NO: C, 81.51; H, 8.79; N, 4.53. Found: C, 81.43; H, 8.80; N, 4.68. IR
(KBr) 3200–3700, 2937, 2857, 2783, 1451, 1339, 1198, 1088, 1061, 1052, 1030, 1020, 771, 751, 705
1
cm−1. H NMR (CDCl3) δ 0.9–1.8 (m, 10H), 2.40 (s, 3H), 2,65 (tt, J=12 Hz, 3 Hz, 1H), 2.74 (d, J=5
Hz, 1H), 5.29 (d, J=5 Hz, 1H), 6.9–7.2 (m, 10H). 13C NMR (CDCl3) δ 26.3, 26.6, 26.7, 27.4, 34.2, 59.0,
72.6, 73.7, 126.5, 126.9, 127.4, 127.8, 129.9, 137.6, 141.8.
3.2.5. (1R,2S)-N-Cyclopentyl-N-methyl-2-amino-1,2-diphenylethanol 8
According to the typical procedure given for 5; 1.18 g (5.53 mmol) (1R,2S)-2-amino-1,2-diphenyl-
ethanol; 651 mg (8.30 mmol) sodium cyanoborohydride; 698 mg (8.30 mmol) cyclopentanone; 22 ml
MeOH; reaction time 3 days at r.t.; column chromatography (hexane:EtOAc, 1:1) of the crude product
afforded the pure secondary amine (1.02 g, 62%) as a colourless oil; 0.8 ml HCOOH, 0.2 ml H2O, 0.6
ml 37% aq. H2CO; reaction time 6 h at 100°C; column chromatography (hexane:EtOAc, 2:1) of crude
product afforded ligand 8 (652 mg, 40%) as colourless crystals: mp 84–85°C. [α]20 −36.1 (c=1.46,
D
CHCl3). Anal. calcd for C20H25NO: C, 81.31; H, 8.53; N, 4.74. Found: C, 81.02; H, 8.84; N, 4.85. IR
(KBr) 3000–3600, 3029, 3088, 2964, 2866, 2804, 1492, 1453, 1088, 1060, 1019, 781, 753, 710, 699, 608
1
cm−1. H NMR (CDCl3) δ 1.3–1.8 (m, 8H), 2.28 (s, 3H), 3.1–3.2 (m, 1H), 3.69 (d, J=6 Hz, 1H), 5.33
(d, J=6 Hz, 1H), 7.0–7.2 (m, 10H). 13C NMR (CDCl3) δ 24.6, 24.7, 26.7, 34.4, 62.6, 73.1, 74.2, 126.8,
127.2, 127.6, 127.9, 128.0, 128.2, 130.0, 137.0, 142.3.
3.2.6. (1R,2S)-N-(2-Morpholinoethyl)-N-methyl-2-amino-1,2-diphenylethanol 9
A suspension of commercially available (1R,2S)-2-amino-1,2-diphenylethanol (799 mg, 3.75 mmol),
N-(2-chloroethyl)-morpholine hydrochloride (837 mg, 4.50 mmol) and K2CO3 (1.04 g, 7.50 mmol) in